What are the responsibilities and job description for the Project Coordinator position at CorMedix Therapeutics?
Why CorMedix Therapeutics?
If you are interested in joining an entrepreneurial team, focused on bringing life-saving therapies to market for critical unmet medical needs, consider applying for a role at CorMedix Therapeutics. The culture at CorMedix Therapeutics is patient-centered where we feel a sense of urgency to solve some of the most pressing issues in hospital-based healthcare.
CorMedix Therapeutic’s greatest asset is our people. We have a deeply experienced team and continue to bring on some of the brightest talent that can problem solve and execute with high precision. We are passionate about the work we do and how we do it. We believe in building highly engaged teams that exude integrity, open communication, and innovation. We believe in fostering each employee to reach their highest potential by offering an inclusive environment, opportunities to challenge yourself and grow, and a community of purpose. We expect that everyone here brings their best selves to work and together, our singular efforts culminate into profound and meaningful breakthroughs.
Company Description: CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. CorMedix is commercializing DefenCath® (taurolidine and heparin) for the prevention of catheter-related bloodstream infections in adult patients undergoing hemodialysis via a central venous catheter. Following its August 2025 acquisition of Melinta Therapeutics LLC, CorMedix is also commercializing a portfolio of anti-infective products, including MINOCIN® (minocycline), REZZAYO® (rezafungin), VABOMERE® (meropenem and vaborbactam), ORBACTIV™ (oritavancin), BAXDELA® (delafloxacin), and KIMYRSA® (oritavancin), as well as TOPROL-XL® (metoprolol succinate). CorMedix Therapeutics has ongoing clinical studies for DefenCath in Total Parenteral Nutrition and Pediatric patient populations and also intends to develop DefenCath as a catheter lock solution for use in other patient populations. REZZAYO is currently approved for the treatment of candidemia and invasive candidiasis in adults, with an ongoing Phase III study for the prophylaxis of IFD in adult patients undergoing allogeneic BMT. Topline results of the Phase III study for REZZAYO are expected in Q2 2026. For more information visit: www.cormedix.com or www.melinta.com. Position:
As the ProjectCoordinator, Portfolio Management Office, you will play an integral role within CorMedix Therapeutics’ Portfolio Management Office and Strategic Operations vertical. This position reports to the Associate Director, Strategic Operations.
In this role, you will work closely with functional leads, project teams, and key internal stakeholders to ensure projects are delivered promptly and executed effectively. This opportunity is ideal for a detail-oriented professional with strong organizational and prioritization skills who is looking to grow within an agile project management environment.
You will help drive project progress by fostering key partnerships with internal stakeholders and applying effective project management practices to keep projects and initiatives on track while facilitating cross-functional communication. You will collaborate with cross-functional teams to ensure the successful execution of business objectives. You will also lead cross-functional conversations with internal stakeholders to help advance initiatives and ensure alignment with organizational goals.
Key Responsibilities
Required
This position is remote with minimal ad hoc travel required. Eastern Time zone is preferred but not required
If you are interested in joining an entrepreneurial team, focused on bringing life-saving therapies to market for critical unmet medical needs, consider applying for a role at CorMedix Therapeutics. The culture at CorMedix Therapeutics is patient-centered where we feel a sense of urgency to solve some of the most pressing issues in hospital-based healthcare.
CorMedix Therapeutic’s greatest asset is our people. We have a deeply experienced team and continue to bring on some of the brightest talent that can problem solve and execute with high precision. We are passionate about the work we do and how we do it. We believe in building highly engaged teams that exude integrity, open communication, and innovation. We believe in fostering each employee to reach their highest potential by offering an inclusive environment, opportunities to challenge yourself and grow, and a community of purpose. We expect that everyone here brings their best selves to work and together, our singular efforts culminate into profound and meaningful breakthroughs.
Company Description: CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. CorMedix is commercializing DefenCath® (taurolidine and heparin) for the prevention of catheter-related bloodstream infections in adult patients undergoing hemodialysis via a central venous catheter. Following its August 2025 acquisition of Melinta Therapeutics LLC, CorMedix is also commercializing a portfolio of anti-infective products, including MINOCIN® (minocycline), REZZAYO® (rezafungin), VABOMERE® (meropenem and vaborbactam), ORBACTIV™ (oritavancin), BAXDELA® (delafloxacin), and KIMYRSA® (oritavancin), as well as TOPROL-XL® (metoprolol succinate). CorMedix Therapeutics has ongoing clinical studies for DefenCath in Total Parenteral Nutrition and Pediatric patient populations and also intends to develop DefenCath as a catheter lock solution for use in other patient populations. REZZAYO is currently approved for the treatment of candidemia and invasive candidiasis in adults, with an ongoing Phase III study for the prophylaxis of IFD in adult patients undergoing allogeneic BMT. Topline results of the Phase III study for REZZAYO are expected in Q2 2026. For more information visit: www.cormedix.com or www.melinta.com. Position:
As the ProjectCoordinator, Portfolio Management Office, you will play an integral role within CorMedix Therapeutics’ Portfolio Management Office and Strategic Operations vertical. This position reports to the Associate Director, Strategic Operations.
In this role, you will work closely with functional leads, project teams, and key internal stakeholders to ensure projects are delivered promptly and executed effectively. This opportunity is ideal for a detail-oriented professional with strong organizational and prioritization skills who is looking to grow within an agile project management environment.
You will help drive project progress by fostering key partnerships with internal stakeholders and applying effective project management practices to keep projects and initiatives on track while facilitating cross-functional communication. You will collaborate with cross-functional teams to ensure the successful execution of business objectives. You will also lead cross-functional conversations with internal stakeholders to help advance initiatives and ensure alignment with organizational goals.
Key Responsibilities
- Develop and maintain integrated project plans, timelines, and critical path analyses
- Identify risks and implement mitigation strategies proactively
- Lead project meetings; document, publish meeting agenda and minutes; drive follow-through on action items
- Promote and maintain a centralized ‘single source of truth’ for project management materials within the company intranet
- Facilitate communication between project teams, vendors, and internal stakeholders
- Promote quality project management methodologies, standards, and best practices
- Assist in monitoring project KPIs for Quarterly Business Reviews
- Prepare and distribute project status updates and reporting for leadership and stakeholders
- Manage calendars, schedule meetings, and organize documentation
Required
- Bachelor’s degree in Business, Management, Communications, Life Sciences or related field
- 1 – 2 years of pharmaceutical industry experience
- Ability to work collaboratively and navigate evolving or ambiguous project requests in a fast-paced environment
- Strong organizational and time-management skills
- Excellent written and verbal communication abilities
- Proficiency with SmartSheet (project management tool) and Microsoft 365 (Teams, Excel, PowerPoint, SharePoint)
- 1–2 years of experience in project coordination, project support, or a related role
- Foundational project management certifications (e.g., CAPM, Google Project Management Certificate) are a plus
This position is remote with minimal ad hoc travel required. Eastern Time zone is preferred but not required
Salary : $90,000 - $116,000